DRTS

Healthcare Biotechnology

Alpha Tau Medical Ltd.

$14.77

-0.23 -1.53% today

Price History

Not enough data

Key Stats

Market Cap

1.37B

Avg Volume

598,415

EPS

-$1.04

52W High

$15.79

52W Low

$3.43

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-27.63

P/B Ratio

30.96

EV/EBITDA

-26.22

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(141.7%)

Return on Assets

(25.7%)

Liquidity & Leverage

Current Ratio

11.09

Quick Ratio

10.45

Debt / Equity

0.34

Total Cash

100.64M

Total Debt

15.15M

About

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.